Showing results (271-280 of 289) with videos related to

Sort By:
Pageof 29
Science Advances|July 24, 2024
In vitro selection and analysis of SARS-CoV-2 nirmatrelvir resistance mutations contributing to clinical virus resistance surveillanceYuao Zhu, Irina Yurgelonis, Stephen Noell, et al.
Journal of Medicinal Chemistry|March 3, 2018
Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of NeuroinflammationLaura A McAllister, Christopher R Butler, Scot Mente, et al.
Journal of Medicinal Chemistry|October 15, 2020
Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19Robert L Hoffman, Robert S Kania, Mary A Brothers, et al.
Acta Neuropathologica|March 19, 2015
Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groupsMichael Weller, Ruthild G Weber, Edith Willscher, et al.
Molecular Systems Biology|May 12, 2025
Metabolic mapping of the human solute carrier superfamilyTabea Wiedmer, Shao Thing Teoh, Eirini Christodoulaki, et al.
Nature Structural & Molecular Biology|December 15, 2022
Structural basis of the acyl-transfer mechanism of human GPAT1Zachary Lee Johnson, Mark Ammirati, David Jonathan Wasilko, et al.
Nature Genetics|March 4, 2025
The contribution of genetic determinants of blood gene expression and splicing to molecular phenotypes and health outcomesAlex Tokolyi, Elodie Persyn, Artika P Nath, et al.
Nature Genetics|June 15, 2026
Single-cell RNA sequencing of terminal ileal biopsies identifies signatures of Crohn's disease pathogenesisMonika Krzak, Tobi Alegbe, D Leland Taylor, et al.
Science (New York, N.Y.)|November 2, 2021
An oral SARS-CoV-2 M<sup>pro</sup> inhibitor clinical candidate for the treatment of COVID-19Dafydd R Owen, Charlotte M N Allerton, Annaliesa S Anderson, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2020
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19Britton Boras, Rhys M Jones, Brandon J Anson, et al.
Pageof 29